ImportRefusal LogoImportRefusal

Violation Code: 336

FDA Violation

Charge Code: INCONSPICU

1,662
Total Refusals
838
Affected Firms
11/25/2025
Latest Case
10/15/2001
First Case

Violation Details

Violation Code (ASC ID)
336
Charge Code
INCONSPICU
Description
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
Legal Section
502(c), 801(a)(3); MISBRANDING

Most Affected Firms

#Firm NameLocationCases
1NATURE REPUBLIC CO., LTD.Seoul, SOUTH KORE75
2Nouvelle Parfumeria GandourAbidjan 01, IVORY COAS40
3Church & Dwight Co., Inc.Lakewood, UNITED STA31
4Frabel Sa De CvCiudad De Mexico, MEXICO27
5Cosbel S.A de C.V.Ciudad De Mexico, MEXICO26
6BRITISH VITATECHLeicester, UNITED KIN23
7FUKUWARAKU COMPANY LTDOsaka, JAPAN23
8TECNO INSTRUMENTS (PVT.) LTD.Sialkot, PAKISTAN22
9The Procter & Gamble CompanyCincinnati, UNITED STA21
10DCS EXPORTBanbury, UNITED KIN20
11U N D ABrussel, BELGIUM20
12Wenzhou Shengkai Technology Industry Co., Ltd.Wenzhou, CHINA15
13Laboratorium Soluna Heilmittel GmbhDonauworth, GERMANY15
14Les Importations Herbasante Inc.Saint-Laurent, CANADA13
15Cipla LimitedSalcette, INDIA13
16Indusrial Clothings LimitedColombo, SRI LANKA11
17Medisca Pharmaceutique Inc.Saint-Laurent, CANADA10
18TIS SANAYI DIS TICARET ASIstanbul, TURKEY10
19Unilever Mexico S de R.L. de C.V.Jiutepec, MEXICO9
20Wenzhou Xinke Electric Co. LtdWenzhou, CHINA9

Recent Import Refusals

DateProductFirm
11/25/2025
PEPTIDE N.E.C.
56FYY99
11/21/2025
OMALIZUMAB
58ACP04
11/14/2025
SYRINGE, PISTON
80FMF
10/31/2025
MISCELLANEOUS PATENT MEDICINES, ETC.
66VIY99
ALLERS GROUPCOLOMBIA
10/29/2025
IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
79LMH
KdermaSOUTH KORE
10/29/2025
IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
79LMH
Exocobio, Inc.SOUTH KORE
10/24/2025
BOTTLED WATER WITH FRUIT FLAVORS, NONCARBONATED (NONMEDICINAL)
29RHT04
10/24/2025
NONCARBONATED SOFT DRINK, N.E.C.
29AHT99
10/9/2025
EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
66YBY99
10/9/2025
SYRINGE, PISTON
80FMF
10/9/2025
PEPTIDE N.E.C.
56FAY99
10/3/2025
STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
63RBY06
HALEONCANADA
10/3/2025
ALUMINUM CHLORIDE ASTRINGENT/ANTI-PERSPIRANT)
62WBU17
10/3/2025
ALUMINUM CHLORIDE ASTRINGENT/ANTI-PERSPIRANT)
62WBU17
9/4/2025
MIXED OR ASSORTED CHOCOLATE CANDIES (BARS, BOXES, LOOSE FORM), WITH NUTS OR NUT PRODUCTS (NOT COCONU
34CMT07

Related Violations

Other violations under the same legal section: 502(c), 801(a)(3); MISBRANDING

CodeCharge CodeCases
3883708NODFL21

Frequently Asked Questions

What is FDA violation code 336?

336 is an FDA violation code that indicates: "Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.". This violation is based on 502(c), 801(a)(3); MISBRANDING of the Federal Food, Drug, and Cosmetic Act.

How many import refusals have been issued for violation 336?

According to FDA Import Refusal data, there have been 1662 import refusals issued for violation code 336, affecting 838 unique firms.

When was the most recent refusal for violation 336?

The most recent import refusal for violation 336 was on November 25, 2025.

What products are commonly refused for violation 336?

Products commonly refused under violation 336 include: PEPTIDE N.E.C., OMALIZUMAB, SYRINGE, PISTON, MISCELLANEOUS PATENT MEDICINES, ETC., IMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE. These products were refused entry because they did not meet FDA requirements.

What is the legal basis for FDA violation code 336?

Violation code 336 is based on 502(c), 801(a)(3); MISBRANDING of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This section of the law establishes requirements that imported products must meet to be allowed entry into the United States.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.